Operating Expenses Summary of Gilead Sciences, Inc.

Gilead Sciences, Inc.'s latest annual operating expenses in 2023 was 13.01 Billion USD , up 10.61% from previous year.
Gilead Sciences, Inc.'s latest quarterly operating expenses in 2024 Q2 was 2.71 Billion USD , down -4.06% from previous quarter.
Gilead Sciences, Inc. reported a annual operating expenses of 10.65 Billion USD in annual operating expenses 2022, up 0.39% from previous year.
Gilead Sciences, Inc. reported a annual operating expenses of 10.6 Billion USD in annual operating expenses 2021, up 4.11% from previous year.
Gilead Sciences, Inc. reported a quarterly operating expenses of 2.71 Billion USD for 2024 Q2, down -4.06% from previous quarter.
Gilead Sciences, Inc. reported a quarterly operating expenses of 3.04 Billion USD for 2023 Q4, up 9.99% from previous quarter.

Annual Operating Expenses Chart of Gilead Sciences, Inc. (2023 - 1990)

Historical Annual Operating Expenses of Gilead Sciences, Inc. (2023 - 1990)

Year	Operating Expenses	Operating Expenses Growth
2023	13.01 Billion USD	10.61%
2022	10.65 Billion USD	0.39%
2021	10.6 Billion USD	4.11%
2020	10.19 Billion USD	-24.45%
2019	13.48 Billion USD	48.63%
2018	9.07 Billion USD	19.21%
2017	7.61 Billion USD	-10.4%
2016	8.49 Billion USD	31.93%
2015	6.44 Billion USD	10.33%
2014	5.83 Billion USD	52.83%
2013	3.81 Billion USD	18.57%
2012	3.22 Billion USD	30.34%
2011	2.47 Billion USD	16.71%
2010	2.11 Billion USD	12.23%
2009	1.88 Billion USD	23.31%
2008	1.52 Billion USD	17.98%
2007	1.29 Billion USD	35.43%
2006	957.52 Million USD	45.75%
2005	656.97 Million USD	24.82%
2004	526.34 Million USD	23.77%
2003	425.24 Million USD	34.55%
2002	316.05 Million USD	1.73%
2001	310.69 Million USD	37.25%
2000	226.36 Million USD	11.07%
1999	203.8 Million USD	86.8%
1998	109.1 Million USD	24.4%
1997	87.7 Million USD	19.97%
1996	73.1 Million USD	92.88%
1995	37.9 Million USD	4.12%
1994	36.4 Million USD	0.0%
1992	24.1 Million USD	138.61%
1991	10.1 Million USD	46.38%
1990	6.9 Million USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	2.83 Billion USD	-7.12%
2024 Q2	2.71 Billion USD	-4.06%
2023 Q4	3.04 Billion USD	9.99%
2023 Q1	2.76 Billion USD	-22.48%
2023 FY	11.78 Billion USD	10.61%
2023 Q2	3.25 Billion USD	17.72%
2023 Q3	2.77 Billion USD	-14.86%
2022 Q3	2.36 Billion USD	-3.94%
2022 Q2	2.45 Billion USD	-50.51%
2022 FY	10.65 Billion USD	0.39%
2022 Q4	3.56 Billion USD	51.06%
2022 Q1	4.96 Billion USD	35.14%
2021 FY	10.6 Billion USD	4.11%
2021 Q1	2.11 Billion USD	-36.22%
2021 Q2	2.48 Billion USD	17.77%
2021 Q3	2.33 Billion USD	-5.96%
2021 Q4	3.67 Billion USD	57.34%
2020 Q1	2.17 Billion USD	-29.84%
2020 Q2	2.53 Billion USD	16.58%
2020 Q4	3.3 Billion USD	46.11%
2020 FY	10.19 Billion USD	-24.45%
2020 Q3	2.26 Billion USD	-10.8%
2019 Q4	3.1 Billion USD	-48.64%
2019 Q1	2.08 Billion USD	-32.26%
2019 FY	13.48 Billion USD	48.63%
2019 Q3	6.04 Billion USD	167.94%
2019 Q2	2.25 Billion USD	8.05%
2018 Q4	3.08 Billion USD	63.28%
2018 FY	9.07 Billion USD	19.21%
2018 Q3	1.88 Billion USD	-13.12%
2018 Q2	2.17 Billion USD	12.31%
2018 Q1	1.93 Billion USD	-19.48%
2017 Q4	2.4 Billion USD	44.0%
2017 Q1	1.78 Billion USD	-19.05%
2017 FY	7.61 Billion USD	-10.4%
2017 Q2	1.76 Billion USD	-1.12%
2017 Q3	1.66 Billion USD	-5.28%
2016 Q2	2.37 Billion USD	21.74%
2016 FY	8.49 Billion USD	31.93%
2016 Q1	1.95 Billion USD	6.97%
2016 Q3	1.97 Billion USD	-16.93%
2016 Q4	2.2 Billion USD	11.56%
2015 Q4	1.82 Billion USD	10.75%
2015 Q3	1.64 Billion USD	0.98%
2015 Q2	1.63 Billion USD	21.55%
2015 Q1	1.34 Billion USD	-30.19%
2015 FY	6.44 Billion USD	10.33%
2014 FY	5.83 Billion USD	52.83%
2014 Q4	1.92 Billion USD	21.94%
2014 Q3	1.57 Billion USD	31.55%
2014 Q1	1.14 Billion USD	7.31%
2014 Q2	1.19 Billion USD	4.76%
2013 Q3	953.1 Million USD	2.61%
2013 FY	3.81 Billion USD	18.57%
2013 Q1	871.92 Million USD	8.25%
2013 Q2	928.89 Million USD	6.53%
2013 Q4	1.06 Billion USD	11.77%
2012 FY	3.22 Billion USD	30.34%
2012 Q4	805.48 Million USD	2.56%
2012 Q3	785.41 Million USD	7.78%
2012 Q2	728.74 Million USD	-19.15%
2012 Q1	901.33 Million USD	20.43%
2011 FY	2.47 Billion USD	16.71%
2011 Q4	748.45 Million USD	27.72%
2011 Q3	585.99 Million USD	-0.12%
2011 Q2	586.67 Million USD	6.66%
2011 Q1	550.01 Million USD	-18.27%
2010 Q2	479.07 Million USD	-1.08%
2010 Q3	480.99 Million USD	0.4%
2010 FY	2.11 Billion USD	12.23%
2010 Q4	672.96 Million USD	39.91%
2010 Q1	484.28 Million USD	-1.88%
2009 FY	1.88 Billion USD	23.31%
2009 Q2	503.04 Million USD	28.09%
2009 Q3	497.28 Million USD	-1.15%
2009 Q4	493.54 Million USD	-0.75%
2009 Q1	392.73 Million USD	-0.71%
2008 Q4	395.52 Million USD	4.84%
2008 Q3	377.25 Million USD	-4.75%
2008 Q2	396.07 Million USD	13.08%
2008 Q1	350.25 Million USD	-3.96%
2008 FY	1.52 Billion USD	17.98%
2007 Q3	313.31 Million USD	-2.73%
2007 Q4	364.69 Million USD	16.4%
2007 Q2	322.11 Million USD	8.58%
2007 Q1	296.64 Million USD	14.66%
2007 FY	1.29 Billion USD	35.43%
2006 FY	957.52 Million USD	45.75%
2006 Q2	242.1 Million USD	4.87%
2006 Q1	230.86 Million USD	33.38%
2006 Q3	225.83 Million USD	-6.72%
2006 Q4	258.71 Million USD	14.56%
2005 Q1	150.56 Million USD	-3.22%
2005 FY	656.97 Million USD	24.82%
2005 Q4	173.09 Million USD	-2.79%
2005 Q3	178.06 Million USD	14.7%
2005 Q2	155.24 Million USD	3.1%
2004 Q1	129.75 Million USD	-8.79%
2004 Q3	121.57 Million USD	1.79%
2004 Q4	155.58 Million USD	27.97%
2004 Q2	119.43 Million USD	-7.96%
2004 FY	526.34 Million USD	23.77%
2003 Q1	88.73 Million USD	-4.22%
2003 Q4	142.26 Million USD	49.34%
2003 Q2	98.99 Million USD	11.56%
2003 Q3	95.26 Million USD	-3.77%
2003 FY	425.24 Million USD	34.55%
2002 Q4	92.63 Million USD	19.29%
2002 FY	316.05 Million USD	1.73%
2002 Q2	72.45 Million USD	-1.18%
2002 Q3	77.65 Million USD	7.18%
2002 Q1	73.31 Million USD	-14.82%
2001 Q1	73.05 Million USD	4.76%
2001 Q3	402.57 Million USD	445.61%
2001 Q2	73.78 Million USD	1.0%
2001 FY	310.69 Million USD	37.25%
2001 Q4	86.07 Million USD	-78.62%
2000 Q1	47.1 Million USD	-12.6%
2000 FY	226.36 Million USD	11.07%
2000 Q2	50.16 Million USD	6.48%
2000 Q3	59.35 Million USD	18.33%
2000 Q4	69.73 Million USD	17.49%
1999 Q2	27 Million USD	8.0%
1999 Q3	55.1 Million USD	104.07%
1999 Q4	53.9 Million USD	-2.18%
1999 FY	203.8 Million USD	86.8%
1999 Q1	25 Million USD	-16.39%
1998 Q3	25.3 Million USD	-7.66%
1998 Q1	26.3 Million USD	-5.4%
1998 Q2	27.4 Million USD	4.18%
1998 Q4	29.9 Million USD	18.18%
1998 FY	109.1 Million USD	24.4%
1997 Q4	27.8 Million USD	34.95%
1997 Q2	21.5 Million USD	21.47%
1997 Q1	17.7 Million USD	-4.32%
1997 FY	87.7 Million USD	19.97%
1997 Q3	20.6 Million USD	-4.19%
1996 Q3	19.6 Million USD	-1.01%
1996 FY	73.1 Million USD	92.88%
1996 Q4	18.5 Million USD	-5.61%
1996 Q2	19.8 Million USD	30.26%
1996 Q1	15.2 Million USD	0.0%
1995 Q2	11 Million USD	-8.33%
1995 Q3	12.1 Million USD	10.0%
1995 FY	37.9 Million USD	4.12%
1995 Q1	12 Million USD	-9.77%
1994 Q3	3.3 Million USD	-67.33%
1994 Q4	13.3 Million USD	303.03%
1994 FY	36.4 Million USD	0.0%
1994 Q1	11 Million USD	14.58%
1994 Q2	10.1 Million USD	-8.18%
1993 Q4	9.6 Million USD	14.29%
1993 Q1	8.3 Million USD	27.69%
1993 Q2	7.3 Million USD	-12.05%
1993 Q3	8.4 Million USD	15.07%
1992 FY	24.1 Million USD	138.61%
1992 Q4	6.5 Million USD	27.45%
1992 Q3	5.1 Million USD	18.6%
1992 Q2	4.3 Million USD	147.25%
1992 Q1	-9.1 Million USD	0.0%
1991 Q1	-6.1 Million USD	0.0%
1991 Q2	- USD	100.0%
1991 Q3	- USD	0.0%
1991 Q4	- USD	0.0%
1991 FY	10.1 Million USD	46.38%
1990 Q3	- USD	0.0%
1990 Q2	- USD	0.0%
1990 Q4	- USD	0.0%
1990 FY	6.9 Million USD	0.0%

Peer Operating Expenses Comparison of Gilead Sciences, Inc.

Name	Operating Expenses	Operating Expenses Difference
Amgen Inc.	11.87 Billion USD	-9.555%
AstraZeneca PLC	29.57 Billion USD	56.004%
Biogen Inc.	5.2 Billion USD	-150.014%
MIRA Pharmaceuticals, Inc.	8.52 Million USD	-152526.363%
Scilex Holding Company	136.49 Million USD	-9433.822%
Scilex Holding Company	136.49 Million USD	-9433.822%

Global Stocks Search

Gilead Sciences, Inc. (GILD)

Operating Expenses Summary of Gilead Sciences, Inc.

Annual Operating Expenses Chart of Gilead Sciences, Inc. (2023 - 1990)

Historical Annual Operating Expenses of Gilead Sciences, Inc. (2023 - 1990)

Peer Operating Expenses Comparison of Gilead Sciences, Inc.